The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Abbvie; ArQule; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; BTG; Gilead Sciences; Kowa; Novartis; Onxeo; OSI Pharmaceuticals; Roche; TERUMO
Research Funding - Bayer

Exposure-response (ER) relationship of regorafenib (REG) in patients with hepatocellular carcinoma (HCC).
 
Alexander Solms
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Bart Ploeger
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Isabel Reinecke
Employment - Bayer
 
Sabine Fiala-Buskies
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Adriaan Cleton
Employment - Bayer
Stock and Other Ownership Interests - Bayer; Pfizer
 
Jordi Bruix
No Relationships to Disclose
 
Gerold Meinhardt
Employment - Bayer
Stock and Other Ownership Interests - Bayer